Envista Holdings (NVST) Total Current Liabilities (2018 - 2026)
Envista Holdings (NVST) posted quarterly Total Current Liabilities of $786.6 million for Q2 2026, down 9.93% year-over-year from $873.3 million in Q2 2025, and down 7.74% quarter-over-quarter from $852.6 million in Q4 2025.
Envista Holdings (NVST) Total Current Liabilities (2018 - 2026) Analysis & Trends
Envista Holdings' Total Current Liabilities history runs 9 years deep, the most recent figure standing at $786.6 million for Q2 2026.
- In Q2 2026, Total Current Liabilities fell 9.93% year-over-year to $786.6 million; the TTM figure through Apr 2026 stood at $786.6 million (down 9.93% YoY), while the FY2025 annual figure was $852.6 million, down 2.97% from the prior year.
- Total Current Liabilities for Q2 2026 stood at $786.6 million, down from $852.6 million in the prior quarter.
- The five-year high for Total Current Liabilities was $1.3 billion in Q3 2022, with the low at $746.8 million in Q3 2023.
- The 5-year median for Total Current Liabilities is $865.5 million (2024), against an average of $959.4 million.
- The sharpest annual moves came in 2023 and 2024: Total Current Liabilities plunged 40.65% in 2023, then grew 15.89% in 2024.
- Envista Holdings' Total Current Liabilities stood at $1.2 billion in 2022, then slumped by 36.86% to $780.8 million in 2023, then increased by 12.54% to $878.7 million in 2024, then fell by 2.97% to $852.6 million in 2025, then dropped by 7.74% to $786.6 million in 2026.
- Business Quant data shows NVST's Total Current Liabilities at $786.6 million in Q2 2026, $852.6 million in Q4 2025, and $821.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 1.92 Bn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 9.40 Bn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 3.17 Bn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 1.40 Bn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 2.71 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 640.50 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 3.66 Bn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 1.80 Bn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 3.59 Bn |
| 10 | Envista Holdings | 4.37 Bn | 3.24 Bn | 407.00 Mn | 807.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 3, 2026 | 807.30 Mn |
| Apr 3, 2026 | 786.60 Mn |
| Dec 31, 2025 | 852.60 Mn |
| Sep 26, 2025 | 821.70 Mn |
| Jun 27, 2025 | 793.90 Mn |
| Mar 28, 2025 | 873.30 Mn |
| Dec 31, 2024 | 878.70 Mn |
| Sep 27, 2024 | 865.50 Mn |
| Jun 28, 2024 | 821.40 Mn |
| Mar 29, 2024 | 781.30 Mn |
| Dec 31, 2023 | 780.80 Mn |
| Sep 29, 2023 | 746.80 Mn |
| Jun 30, 2023 | 1.15 Bn |
| Mar 31, 2023 | 1.15 Bn |
| Dec 31, 2022 | 1.24 Bn |
| Sep 30, 2022 | 1.26 Bn |
| Jul 1, 2022 | 1.26 Bn |
| Apr 1, 2022 | 1.26 Bn |
| Dec 31, 2021 | 1.21 Bn |
| Oct 1, 2021 | 1.27 Bn |